Results 101 to 110 of about 9,288 (216)

Urticaria multiforme-like eruption due to a novel agent elexacaftor/tezacaftor/ivacaftor in a pediatric patient with cystic fibrosis

JAAD Case Reports, 2021
Rebecca H. Goldberg, BS, Natalie H. Matthews, MD, MPhil, Alexandra C. Hristov, MD, Frank Wang, MD   +3 more
doaj   +1 more source

Impact of CFTR modulator concentrations on clinical response in cystic fibrosis. [PDF]

Eur Respir J
Chalamalla AR, Baker E, Ryan KJ, Dowell A, Natt JR, Zemanick ET, Konstan MW, Mayer-Hamblett N, Acosta EP, Guimbellot JS, CHEC-SC investigators.   +10 more
europepmc   +1 more source

In Vitro Restoration of Colistin Susceptibility by Ivacaftor Synergy with Limited Reproducibility in a Murine Pneumonia Model. [PDF]

Antibiotics (Basel)
Halperin AV, Schwartz F, Christophersen L, Pérez-Del Palacio J, Ponce-Alonso M, Avendaño-Ortiz J, Caballero JD, Cantón R, Moser C, Del Campo R.   +9 more
europepmc   +1 more source

Effect of elexacaftor-tezacaftor-ivacaftor therapy on systemic inflammation in people with cystic fibrosis. [PDF]

J Bras Pneumol
Meyer VMC, Aranha Netto N, Palmeira P, Athanazio RA, Silva-Filho LVRFD.   +4 more
europepmc   +1 more source

Clinical Outcomes in Concurrent Cohorts of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA)-Treated versus ELX/TEZ/IVA-Ineligible Individuals with Cystic Fibrosis in the US during COVID-19. [PDF]

Pulm Ther
Merlo CA, Romdhani H, DerSarkissian M, Muthukumar A, McGarry LJ, Lou Y, Van Brunt K.   +6 more
europepmc   +1 more source

Long-Term Adherence to Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis. [PDF]

Pulm Ther
Hansen CME, Zendaky B, Zwitserloot AM, van den Bemt PMLA, van Boven JFM.   +4 more
europepmc   +1 more source

Altered functional interactions between CFTR disease mutants ΔF508 and G551D and the protein kinase A catalytic subunit. [PDF]

J Physiol
Závoti O, Simon MA, Csanády L.
europepmc   +1 more source

Off-label treatment with elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis: real-world evidence from the German CF Registry. [PDF]

ERJ Open Res
Stahl M, Gerts FS, Hafkemeyer S, Wosniok J, Naehrlich L, German CF Registry of the Mukoviszidose e.V. and participating sites.   +5 more
europepmc   +1 more source

Predictive capacity of paediatric nasal epithelial cells in sequential CFTR modulator therapy. [PDF]

Thorax
Fawcett LK, Chew ZA, Schneider-Futschik EK, Allan KM, Patel HR, Jaffe A, Waters S.   +6 more
europepmc   +1 more source

Management of Infants Exposed to Prenatal and Postnatal Elexacaftor/Tezacaftor/Ivacaftor: A Cross-Sectional Survey. [PDF]

Health Sci Rep
Haskett H, Ren CL.
europepmc   +1 more source